LoginSignup
BAV

Bavarian Nordic

Stock
Stock
ISIN: DK0061268711
DK0061268711

Price

Price

Frequently asked questions

What is Bavarian Nordic's market capitalization?

The market capitalization of Bavarian Nordic is $2.12B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Bavarian Nordic's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Bavarian Nordic is 13.40. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Bavarian Nordic?

Bavarian Nordic's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 2.006. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Bavarian Nordic's stock?

Currently, 7 analysts cover Bavarian Nordic's stock, with a consensus target price of $39.30. Analyst ratings provide insights into the stock's expected performance.

What is Bavarian Nordic's revenue over the trailing twelve months?

Over the trailing twelve months, Bavarian Nordic reported a revenue of $847.96M.

What is the EBITDA for Bavarian Nordic?

Bavarian Nordic's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $438.45M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Bavarian Nordic?

Bavarian Nordic has a free cash flow of $38.97M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Bavarian Nordic's stock?

The 5-year beta for Bavarian Nordic is 1.71. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Bavarian Nordic have, and what sector and industry does it belong to?

Bavarian Nordic employs approximately 1,609 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Bavarian Nordic's shares?

The free float of Bavarian Nordic is 77.29M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $2.12B

5Y beta

 1.71

EPS (TTM)

 2.006

Free Float

 77.29M

P/E ratio (TTM)

 13.40

Revenue (TTM)

 $847.96M

EBITDA (TTM)

 $438.45M

Free Cashflow (TTM)

 $38.97M

Analyst Ratings

The price target is $39.30 and the stock is covered by 7 analysts.

Buy

7

Hold

0

Sell

0

Information

Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in manufacturing of pharmaceutical preparations. The Company is involved in research and development innovations, production and commercialization of life-saving vaccines based on viral vectors for the delivery of antigens targeting infectious diseases. Bavarian Nordic A/S offers travel health products including cholera, rabies, tick-borne encephalitis and typhoid vaccines, as well as vaccines sold and distributed in selected markets on behalf of third parties. The Company deals with vaccines aimed at improving public health and preparedness. Bavarian Nordic A/S focuses on vaccine solutions that help address the threat of infectious diseases. The Company operates worldwide.

1,609

Biotechnology & Drugs

Health Care

Identifier

ISIN

DK0061268711

Knockouts

Join the conversation
Sign upLogin